OneMedNet Corporation (NASDAQ:ONMD – Get Free Report) CEO Aaron Green acquired 18,702 shares of OneMedNet stock in a transaction on Monday, June 15th. The stock was purchased at an average cost of $0.54 per share, for a total transaction of $10,099.08. Following the purchase, the chief executive officer owned 1,859,725 shares in the company, valued at approximately $1,004,251.50. The trade was a 1.02% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Aaron Green also recently made the following trade(s):
- On Friday, June 12th, Aaron Green bought 36,920 shares of OneMedNet stock. The stock was bought at an average price of $0.56 per share, with a total value of $20,675.20.
OneMedNet Stock Performance
Shares of OneMedNet stock opened at $0.56 on Tuesday. The stock has a market cap of $30.37 million, a price-to-earnings ratio of -11.16 and a beta of 1.12. The stock has a 50 day moving average price of $0.87 and a 200-day moving average price of $0.96. OneMedNet Corporation has a one year low of $0.31 and a one year high of $4.22.
Hedge Funds Weigh In On OneMedNet
Large investors have recently bought and sold shares of the business. Virtu Financial LLC purchased a new position in OneMedNet during the 4th quarter valued at $48,000. State Street Corp boosted its holdings in OneMedNet by 41.5% during the 4th quarter. State Street Corp now owns 116,700 shares of the company’s stock valued at $128,000 after acquiring an additional 34,200 shares during the period. Jane Street Group LLC purchased a new position in OneMedNet during the 4th quarter valued at $119,000. HRT Financial LP purchased a new position in OneMedNet during the 4th quarter valued at $32,000. Finally, Exencial Wealth Advisors LLC boosted its holdings in OneMedNet by 1.3% during the 4th quarter. Exencial Wealth Advisors LLC now owns 3,644,861 shares of the company’s stock valued at $4,009,000 after acquiring an additional 45,401 shares during the period. Hedge funds and other institutional investors own 0.95% of the company’s stock.
Analyst Ratings Changes
A number of equities analysts have recently commented on ONMD shares. Wall Street Zen cut OneMedNet from a “hold” rating to a “sell” rating in a report on Saturday, May 23rd. Weiss Ratings reiterated a “sell (e+)” rating on shares of OneMedNet in a report on Monday, June 1st. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Sell”.
Check Out Our Latest Analysis on OneMedNet
About OneMedNet
OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.
Further Reading
- Five stocks we like better than OneMedNet
- 3 AI Stocks With Moats That Could Outlast Summer Volatility
- These 5 Companies Just Made a Massive Bet on Themselves
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
- RH’s Strong Q1 Still Leaves Investors With One Big Question
Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.
